Publication
Logo

Only followers of this user (@HopeAlways888) can see their posts

Avatar
Patricia Maples @TrishM

The emergency use authorization was only narrowly approved (13-10) because of questions regarding efficacy and concerns that molnupiravir's mutagenic effects could create new variants that evade immunity and prolong the COVID-19 pandemic.

In response Hope Always888 to her Publication

Only people mentioned by @TrishM in this post can reply

No replys yet!

It seems that this publication does not yet have any comments. In order to respond to this publication from Patricia Maples, click on at the bottom under it